You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

BLEOMYCIN SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Bleomycin Sulfate patents expire, and what generic alternatives are available?

Bleomycin Sulfate is a drug marketed by Cipla, Fresenius Kabi Usa, Hikma, Hospira, Meitheal, Pharmachemie Bv, Teva Parenteral, and Teva Pharms Usa. and is included in eight NDAs.

The generic ingredient in BLEOMYCIN SULFATE is bleomycin sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Bleomycin Sulfate

A generic version of BLEOMYCIN SULFATE was approved as bleomycin sulfate by HOSPIRA on March 10th, 2000.

  Try a Trial

Drug patent expirations by year for BLEOMYCIN SULFATE
Recent Clinical Trials for BLEOMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Jinnah Postgraduate Medical CentrePhase 2
University of ArkansasPhase 1
AIDS Malignancy ConsortiumPhase 1

See all BLEOMYCIN SULFATE clinical trials

Pharmacology for BLEOMYCIN SULFATE
Medical Subject Heading (MeSH) Categories for BLEOMYCIN SULFATE

US Patents and Regulatory Information for BLEOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 209439-001 Mar 11, 2019 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 065031-002 Mar 10, 2000 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 065042-002 Oct 17, 2001 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Parenteral BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 064084-002 Jun 1, 1996 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Meitheal BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 205030-001 Apr 20, 2018 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.